Arteris (AIP) CEO-linked LLC sells 40,000 shares under 10b5-1 plan

Rhea-AI Filing Summary

Arteris, Inc. President and CEO Charles K. Janac, through Bayview Legacy, LLC, reported open-market sales of 40,000 shares of Arteris common stock on March 25–26, 2026 at weighted average prices of $18.0309 and $18.3458. These trades were executed under a Rule 10b5-1 trading plan adopted on March 5, 2025. Following the transactions, Bayview Legacy, LLC holds 9,189,071 shares indirectly, while separate holding entries show Janac with 217,538 shares held directly and 56,252 shares held through the Charles and Lydia Janac Trust.

Insider Trade Summary 10b5-1

Net Seller: 40,000 shares ($731,624)

Net Sell 4 txns

Insider JANAC K CHARLES

Role President and CEO

Sold 40,000 shs ($732K)

Type	Security	Shares	Price	Value
Sale	Common Stock	32,988	$18.3458	$605K
Sale	Common Stock	7,012	$18.0309	$126K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 9,189,071 shares (Indirect, Bayview Legacy, LLC); Common Stock — 217,538 shares (Direct)

Footnotes (1)

1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 5, 2025. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.08 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The Reporting Person is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy, LLC. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.70 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The shares are held by Charles and Lydia Janac Trust, for which the Reporting Person serves as trustee.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

JANAC K CHARLES

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CALIFORNIA 95008

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/25/2026		S(1)		7,012	D	$18.0309(2)	9,222,059	I	Bayview Legacy, LLC(3)
Common Stock	03/26/2026		S(1)		32,988	D	$18.3458(4)	9,189,071	I	Bayview Legacy, LLC(3)
Common Stock								217,538	D
Common Stock								56,252	I	Charles and Lydia Janac Trust(5)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 5, 2025.

2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.08 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The Reporting Person is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy, LLC.

4. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.70 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

5. The shares are held by Charles and Lydia Janac Trust, for which the Reporting Person serves as trustee.

	/s/ Paul Alpern, as Attorney-in-Fact for K. Charles Janac	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Arteris (AIP) report for Charles K. Janac?

Arteris reported that an entity associated with President and CEO Charles K. Janac sold 40,000 shares of common stock in open-market transactions. The sales occurred on March 25–26, 2026 at weighted average prices around $18 per share.

Who actually sold the Arteris (AIP) shares in this Form 4 filing?

The shares were sold by Bayview Legacy, LLC, which holds Arteris common stock and is managed by Charles K. Janac. As manager, he is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.

How many Arteris (AIP) shares did Bayview Legacy, LLC sell and at what prices?

Bayview Legacy, LLC sold a total of 40,000 Arteris common shares. One block of 7,012 shares was sold at a weighted average price of $18.0309 and another 32,988 shares at a weighted average price of $18.3458, across multiple trades.

Was the Arteris (AIP) insider sale made under a Rule 10b5-1 plan?

Yes. The filing states the transaction was made under a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2025. Such plans pre-schedule trades, making the timing more routine rather than discretionary.

How many Arteris (AIP) shares does Bayview Legacy, LLC hold after the sale?

After the reported transactions, Bayview Legacy, LLC holds 9,189,071 shares of Arteris common stock. This figure represents the indirect holdings associated with Charles K. Janac through the LLC following the March 25–26, 2026 sales.

What additional Arteris (AIP) holdings does Charles K. Janac report?

Beyond the Bayview Legacy, LLC position, the Form 4 shows 217,538 Arteris shares held directly by Charles K. Janac and 56,252 shares held through the Charles and Lydia Janac Trust, for which he serves as trustee.